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R919and, more importantly, correlated with
behavior, as a low dose insufficient
to induce unconsciousness also failed
to significantly increase VLPO activity.
In addition, VLPO lesions in mice
produced an acute resistance to
isoflurane-induced unconsciousness,
further suggesting that VLPO neurons
are a target for isoflurane. However,
while c-Fos and lesion data may be
suggestive of a mechanism, they are
not definitive.
The highlight of this paper [2] is
the electrophysiological work using
hypothalamic slices. The authors
report that isoflurane selectively
depolarized NA(–) cells, the subtype of
VLPO neurons thought to promote
sleep. Surprisingly, the excitatory
effects of isoflurane were
extrasynaptic. In other words, rather
than indirectly activating VLPO neurons
through synaptic inputs, isoflurane
directly depolarized VLPO neurons.
The authors go a step further and show
that closure of a background
potassium conductance is the likely
mechanism.
The vast majority of
electrophysiological work to date has
found that anesthetics enhance
inhibitory receptors or inhibit excitatory
receptors, and in either case the
common end result is neuronal
depression. Although direct activation
of central respiratory chemoreceptor
neurons by isoflurane has been
previously reported [20], direct
anesthetic-induced depolarization of
neurons is a highly unusual finding.
More importantly, the discovery that
isoflurane selectively activates
sleep-promoting NA(–) neurons in the
VLPO supports an emerging concept
that anesthetics contribute to
unconsciousness through specific
effects at discrete neural circuits that
regulate sleep and wakefulness.
Future Directions
The mechanisms of general anesthesia
have evolved from an elusive
pharmacology puzzle to a tractable
neuroscience problem. Despite
considerable advances in our
knowledge of the molecular effects
of anesthetics, much remains to be
learned about the profound and
complex changes that occur at the
level of neural circuits and systems
during general anesthesia. With our
current knowledge of the molecular
mechanisms of general anesthesia and
the neurobiology of arousal, it hasbecome feasible to apply a systems
neuroscience analysis to the problem
[17]. Such analyses will provide
a framework to explore and better
understand the mechanisms of general
anesthesia.References
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a Root?The plant hormone cytokinin controls root growth by balancing the division and
differentiation of stem cells. But what controls accumulation of cytokinin?
A new study has identified a regulatory loop between a transcription factor,
PHABULOSA, and cytokinin biosynthesis that creates robust domains of
cytokinin activity.Anthony Bishopp1,
Robertas Ursache2,
and Yka¨ Helariutta2,*
Root growth is a highly variable
process that is dependent on
environmental stimuli. It iscoordinated by a small population of
undifferentiated stem cells close to the
root tip (known as themeristem). These
cells undergo several rounds of cell
division before they elongate and finally
differentiate [1]. The rate of root growth
and the size of the meristem are
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Figure 1. The long and short of it: mechanisms for controlling root length.
(Left) The growing Arabidopsis root can be separated into three overlapping regions. In the
meristematic zone (MZ) cells are competent to divide. After several rounds of division,
daughter cells enter an elongation/differentiation zone (EDZ). The point at which cells start
to elongate varies between the different cell lineages and has been broadly classified as the
transition zone (TZ). (Right) Schematic model showing the regulatory network controlling
the interplay between cytokinin and PHABULOSA. (Root image provided by Shunsuke
Miyashima.)
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R920determined by the collective output of
cell division, cell elongation and cell
differentiation (Figure 1A).
More than 50 years ago, researchers
identified the plant hormone cytokinin
as a factor inhibiting root growth [2].
Cytokinin has since been shown to
mediate this effect by controlling the
size of the meristem [3–5]. However,
only now are we beginning to
understand how a stable zone of
cytokinin is maintained in the root
meristem. In a recent issue of Current
Biology, Dello Ioio and colleagues [6]
report that the expression of IPT7
(a rate-limiting component of the
cytokinin biosynthesis pathway) is
directly regulated by the transcription
factor PHABULOSA (PHB). This
activation occurs in the context of an
elegant regulatory loop with PHB and
the authors propose that through this,
cytokinin limits its own activity. They
provide convincing support for this
concept using a combination of
experimental techniques and
mathematical simulations.
PHABULOSA is a member of
the class III HD-ZIP gene family. InArabidopsis, this family is represented
by five members that have overlapping
roles in the specification of
organ polarity and patterning [7,8].
All five genes are expressed in the
root meristem and act as
dosage-dependent regulators to
specify vascular cell identity in roots
[9]. Dello Ioio et al. [6] observed that the
two class III HD-ZIP proteins
PHABULOSA and PHAVOLUTA (PHV)
also control meristem size. They
observed that the heterozygous
dominant gain-of-function alleles
phb-1d/+ and phv-1d/+ develop short
roots and smaller meristems. In these
mutant alleles the PHB or PHV
transcripts are rendered resistant to
regulation by microRNA165/6 and the
domains in which they are expressed
become broader [9–11]. To test
whether these genes were required in
regulating meristem size, Dello Ioio
et al. [6] observed that in the double
loss-of-function phb phv mutant,
plants had longer roots with larger
meristems. But how do PHB and PHV
fit into the existing framework
regulating meristem size?The phenotypes that Dello Ioio et al.
[6] observed in the phb1d/+ and
phv1d/+ gain-of-function alleles
closely resemble those of plants
supplied with exogenous cytokinin;
the phb phv loss-of-function mutant
closely resembles lines in which
cytokinin signalling is impaired [3].
They examined several conditions in
which cytokinin levels or signalling
were altered and observed that
the meristem phenotypes of the
gain-of-function mutants could be
suppressed when the cytokinin
response regulator ARR1was knocked
out. They also observed that supplying
exogenous cytokinin could
complement the meristem size
phenotype of the loss-of-function
phb phv mutant. Together these
results neatly demonstrate that
PHB/PHV act to control meristem size
by controlling cytokinin action, most
likely through modulating cytokinin
synthesis.
The idea of a group of specific
transcription factors promoting the
site-specific biosynthesis of cytokinin
is very attractive. One source of
cytokinin in the root meristem is via
transport through the phloem. While
this is important in certain processes,
such as vascular patterning in the root
meristem [12], degradation of
phloem-derived cytokinin has no
bearing on meristem size [13]. Could
PHB/PHV promote cytokinin
biosynthesis to generate the local
supply of cytokinin required to regulate
root growth?
To investigate this, Dello Ioio and
colleagues [6] focused on the isopentyl
transferase gene family (IPT). Cytokinin
synthesis requires multiple steps, but
the rate-limiting step is catalyzed by
the IPTs [14,15]. They discovered
that expression of IPT7 is reduced in
phb phv and increased in both the
phb1d/+ and phv1d/+ gain-of-function
mutants. Crucially, they noted that IPT7
is a direct target of PHB. The key
experiment came when they
miss-expressed IPT7 in the phb phv
double mutant, and were able to
completely restore the wild-type root
length and meristem size. Coupled
with the observation that meristem
size is indistinguishable in ipt7, phb
phv and phb phv ipt7, this shows
convincingly that PHB controls root
growth through modulating cytokinin
biosynthesis.
How does this fit in with the existing
knowledge of cytokinin action? In
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R921addition to cytokinin, the hormone
auxin also plays a pivotal role in
specifying the zone where cells
differentiate [3,16]. This coordination
is achieved through the activation
of the auxin response inhibitor
SHY2 by the cytokinin response
regulators ARR1 and ARR12
[17,18]. The cytokinin-mediated
expression of SHY2 negatively
regulates the expression of the PIN
class of auxin transporters to
restrict the domain of auxin output
and promote cell differentiation
[17,18]. Additionally, SHY2 represses
the cytokinin biosynthesis gene
IPT5 to create a negative feedback
loop [17].
It is known that cytokinin action is
self-limiting and feeds back on the
expression of IPTs after a certain
threshold [14]. The new data presented
by Dello Ioio et al. [6] show that this
mechanism could be achieved partly
through PHB. PHB expression is
rapidly reduced when plants are
supplied with exogenous cytokinin. In
addition to the transcriptional
repression of PHB, Dello Ioio et al.
also observed that cytokinin represses
the expression of microRNA165A.
As microRNA165/6 has previously
been shown to function in the
post-transcriptional repression of
PHB [9,11], the authors propose
that this mechanism provides
a feed-forward loop to regulate PHB
activity. Such a loop comprises three
components; the first component
(ARR1) regulates the activity of the
second component (PHABULOSA)
by two means (Figure 1B). On one
hand ARR1 represses the transcription
of PHB (shown in Figure 1B in blue);
and on the other hand ARR1
represses the expression of a third
component (microRNA165/6) that
exerts post-transcriptional repression
of PHB (shown in red). PHB promotes
the biosynthesis of cytokinin (via IPT7),
which activates ARR1 (shown in green).
This provides a molecular circuit
whereby cytokinin both represses PHB
and prevents the repression of PHB,
which in turn feeds back on the
synthesis of the original signalling
molecule, cytokinin. The authors refer
to this system as an incoherent
feedforward loop.
But why would such a complicated
regulatory network be required to
restrict the spatial domain of cytokinin?
In order to answer this question, Dello
Ioio et al. [6] ran a series ofmathematical simulations of this
molecular network with, and without,
the regulation of microRNA165/6 by
cytokinin. They discovered that
this regulatory loop dampens the
reduction and accelerates the recovery
of PHB levels as cytokinin levels
fluctuate. This network is therefore
likely to provide a robust mechanism
that can position the boundary
between cell division and cell
differentiation to determine meristem
size.
In summary, the work presented by
Dello Ioio et al. provides a complex yet
elegant molecular network to provide
stable levels of cytokinin. Cytokinin
action then determines the point at
which cell differentiation occurs,
thereby controlling the size of the root
meristem as well as the overall growth
of the root. One truly exciting aspect
about this work is that many of the
same components regulate other
aspects of root development. For
example, auxin, cytokinin, PHB and
microRNA165/6 all regulate vascular
pattern formation [9,13]. Auxin and
cytokinin control root and shoot
branching [19,20]. It will be fascinating
to see if similar molecular networks
also specify the positioning of cytokinin
output during these developmental
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